Tag: EACTS 2023
EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”
Data from the On-X ao...
Artivion announces meaningful all-cause mortality reduction in AMDS PERSEVERE trial
Artivion has announced pr...





